CSI Market
Sign In | Register

Curevac N v (CVAC) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access CVAC Annual Income Statement →
Income statement data covering Curevac N v–Dec 31 2023 offers a view into how Dec 31 2024's operating results have moved alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
Q4 2024 		0 0 0 (Dec 31 2023)
Revenues
Revenue From Contracts With Customers599.40
Total Revenue599.40
Costs & Expenses
Cost of Goods and Services Sold118.53
Gross Profit480.87
Selling, Administration, Marketing78.05
Depreciation & Amortization0.00
Research and Development Expense171.40
Other Operating Expense / -Income0.00
Total operating costs including COS400.40
Operating income / -loss199.00
Net Interest Expense / -Income0.00
Other loss / -income-14.78
Total costs & expenses385.61
Income & Taxes
Income / -loss before income taxes213.79
Income taxes expenses / -benefit32.14
Income after income taxes181.65
Income / -loss from continuing operations181.65
Net income / -loss181.65
Income / -loss to shareholder-35.00
EBIT213.79
EBITD213.79
EBITDA213.79
Earnings Per Share
Basic EPS (excl. extra items)-0.15
Basic Net EPS-0.15
Basic shares outstanding (Mill. of Units)224.38
Diluted Net EPS-0.15
Diluted average shares (Mill. of Units)225.27
4 historic quarters locked

Sign in to unlock the full Curevac N v income statement history.

Sign In Create Free Account

About CVAC Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.